These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
175 related articles for article (PubMed ID: 19424974)
1. Prognostic significance of molecular markers in oral squamous cell carcinoma: a multivariate analysis. Shah NG; Trivedi TI; Tankshali RA; Goswami JV; Jetly DH; Shukla SN; Shah PM; Verma RJ Head Neck; 2009 Dec; 31(12):1544-56. PubMed ID: 19424974 [TBL] [Abstract][Full Text] [Related]
2. Prognostic significance of biomarkers in squamous cell carcinoma of the tongue: multivariate analysis. Vora HH; Shah NG; Patel DD; Trivedi TI; Chikhlikar PR J Surg Oncol; 2003 Jan; 82(1):34-50. PubMed ID: 12501167 [TBL] [Abstract][Full Text] [Related]
3. Prognostic significance of clinical parameters and biological markers in patients with squamous cell carcinoma of the head and neck treated with concurrent chemoradiotherapy. Homma A; Furuta Y; Oridate N; Nakano Y; Kohashi G; Yagi K; Nagahashi T; Yagi K; Nagahashi T; Fukuda S; Inoue K; Inuyama Y Clin Cancer Res; 1999 Apr; 5(4):801-6. PubMed ID: 10213215 [TBL] [Abstract][Full Text] [Related]
4. Prognostic significance of tumor angiogenesis, Ki 67, p53 oncoprotein, epidermal growth factor receptor and HER2 receptor protein expression in undifferentiated nasopharyngeal carcinoma--a prospective study. Ma BB; Poon TC; To KF; Zee B; Mo FK; Chan CM; Ho S; Teo PM; Johnson PJ; Chan AT Head Neck; 2003 Oct; 25(10):864-72. PubMed ID: 12966511 [TBL] [Abstract][Full Text] [Related]
5. Bilharzial related, organ confined, muscle invasive bladder cancer: prognostic value of apoptosis markers, proliferation markers, p53, E-cadherin, epidermal growth factor receptor and c-erbB-2. Haitel A; Posch B; El-Baz M; Mokhtar AA; Susani M; Ghoneim MA; Marberger M J Urol; 2001 May; 165(5):1481-7. PubMed ID: 11342901 [TBL] [Abstract][Full Text] [Related]
7. Predictive and prognostic markers in a series of patients with head and neck squamous cell invasive carcinoma treated with concurrent chemoradiation therapy. Gasparini G; Bevilacqua P; Bonoldi E; Testolin A; Galassi A; Verderio P; Boracchi P; Guglielmi RB; Pezzella F Clin Cancer Res; 1995 Nov; 1(11):1375-83. PubMed ID: 9815934 [TBL] [Abstract][Full Text] [Related]
8. Immunohistochemical analysis with multiple antibodies in search of prognostic markers for clear cell renal cell carcinoma. Phuoc NB; Ehara H; Gotoh T; Nakano M; Yokoi S; Deguchi T; Hirose Y Urology; 2007 May; 69(5):843-8. PubMed ID: 17482919 [TBL] [Abstract][Full Text] [Related]
9. Molecular marker expression in oral and oropharyngeal squamous cell carcinoma. Smith BD; Smith GL; Carter D; DiGiovanna MP; Kasowitz KM; Sasaki CT; Haffty BG Arch Otolaryngol Head Neck Surg; 2001 Jul; 127(7):780-5. PubMed ID: 11448349 [TBL] [Abstract][Full Text] [Related]
10. The prognostic significance of p53, Ki-67, epithelial cadherin and matrix metalloproteinase-9 in penile squamous cell carcinoma treated with surgery. Zhu Y; Zhou XY; Yao XD; Dai B; Ye DW BJU Int; 2007 Jul; 100(1):204-8. PubMed ID: 17433031 [TBL] [Abstract][Full Text] [Related]
11. p14ARF protein expression is a predictor of both relapse and survival in squamous cell carcinoma of the anterior tongue. Kwong RA; Kalish LH; Nguyen TV; Kench JG; Bova RJ; Cole IE; Musgrove EA; Sutherland RL Clin Cancer Res; 2005 Jun; 11(11):4107-16. PubMed ID: 15930346 [TBL] [Abstract][Full Text] [Related]
12. P53 and Ki-67 as outcome predictors for advanced squamous cell cancers of the head and neck treated with chemoradiotherapy. Lavertu P; Adelstein DJ; Myles J; Secic M Laryngoscope; 2001 Nov; 111(11 Pt 1):1878-92. PubMed ID: 11801963 [TBL] [Abstract][Full Text] [Related]
13. p53 and cyclin D1 as prognostic factors in squamous cell carcinoma of the larynx. Vielba R; Bilbao J; Ispizua A; Zabalza I; Alfaro J; Rezola R; Moreno E; Elorriaga J; Alonso I; Baroja A; de la Hoz C Laryngoscope; 2003 Jan; 113(1):167-72. PubMed ID: 12514403 [TBL] [Abstract][Full Text] [Related]
14. p21WAF1/CIP1 expression is a marker of poor prognosis in oral squamous cell carcinoma. Nemes JA; Nemes Z; Márton IJ J Oral Pathol Med; 2005 May; 34(5):274-9. PubMed ID: 15817070 [TBL] [Abstract][Full Text] [Related]
15. The prognostic significance of multiple morphologic features and biologic markers in ductal carcinoma in situ of the breast: a study of a large cohort of patients treated with surgery alone. Cornfield DB; Palazzo JP; Schwartz GF; Goonewardene SA; Kovatich AJ; Chervoneva I; Hyslop T; Schwarting R Cancer; 2004 Jun; 100(11):2317-27. PubMed ID: 15160334 [TBL] [Abstract][Full Text] [Related]
16. Cyclin D1 gene numerical aberration is a predictive marker for occult cervical lymph node metastasis in TNM Stage I and II squamous cell carcinoma of the oral cavity. Myo K; Uzawa N; Miyamoto R; Sonoda I; Yuki Y; Amagasa T Cancer; 2005 Dec; 104(12):2709-16. PubMed ID: 16265665 [TBL] [Abstract][Full Text] [Related]
17. Clinical significance of c-myc and p53 expression in head and neck squamous cell carcinomas. Waitzberg AF; Nonogaki S; Nishimoto IN; Kowalski LP; Miguel RE; Brentani RR; Brentani MM Cancer Detect Prev; 2004; 28(3):178-86. PubMed ID: 15225897 [TBL] [Abstract][Full Text] [Related]
18. Detection of survivin and p53 in human oral cancer: correlation with clinicopathologic findings. Khan Z; Tiwari RP; Mulherkar R; Sah NK; Prasad GB; Shrivastava BR; Bisen PS Head Neck; 2009 Aug; 31(8):1039-48. PubMed ID: 19340865 [TBL] [Abstract][Full Text] [Related]
19. The prevalence and clinicopathologic correlate of p16INK4a, retinoblastoma and p53 immunoreactivity in locally advanced urinary bladder cancer. Tzai TS; Tsai YS; Chow NH Urol Oncol; 2004; 22(2):112-8. PubMed ID: 15082007 [TBL] [Abstract][Full Text] [Related]
20. Correlation of expression of Ki-67, EGFR, c-erbB-2, MMP-9, p53, bcl-2, CD34 and cell cycle analysis with survival in head and neck squamous cell cancer. Smilek P; Dusek L; Veselý K; Rottenberg J; Kostrica R J Exp Clin Cancer Res; 2006 Dec; 25(4):549-55. PubMed ID: 17310847 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]